A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say - statnews.com
07.06.2025 16:50
In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly obesity treatment that targeted three hormones at once. In mice studies, the drug, which activated receptors … [+1550 chars]